These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26111647)

  • 1. Pyruvate and cilostazol protect cultured rat cortical pericytes against tissue plasminogen activator (tPA)-induced cell death.
    Kim HN; Kim TY; Yoon YH; Koh JY
    Brain Res; 2015 Dec; 1628(Pt B):317-326. PubMed ID: 26111647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurovascular protection of cilostazol in stroke-prone spontaneous hypertensive rats associated with angiogenesis and pericyte proliferation.
    Omote Y; Deguchi K; Kono S; Liu N; Liu W; Kurata T; Yamashita T; Ikeda Y; Abe K
    J Neurosci Res; 2014 Mar; 92(3):369-74. PubMed ID: 24375726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA.
    Ishiguro M; Mishiro K; Fujiwara Y; Chen H; Izuta H; Tsuruma K; Shimazawa M; Yoshimura S; Satoh M; Iwama T; Hara H
    PLoS One; 2010 Dec; 5(12):e15178. PubMed ID: 21151895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc-triggered induction of tissue plasminogen activator by brain-derived neurotrophic factor and metalloproteinases.
    Hwang IY; Sun ES; An JH; Im H; Lee SH; Lee JY; Han PL; Koh JY; Kim YH
    J Neurochem; 2011 Sep; 118(5):855-63. PubMed ID: 21615740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilostazol ameliorates collagenase-induced cerebral hemorrhage by protecting the blood-brain barrier.
    Takagi T; Imai T; Mishiro K; Ishisaka M; Tsujimoto M; Ito H; Nagashima K; Matsukawa H; Tsuruma K; Shimazawa M; Yoshimura S; Kozawa O; Iwama T; Hara H
    J Cereb Blood Flow Metab; 2017 Jan; 37(1):123-139. PubMed ID: 26661252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator disrupts the blood-brain barrier through increasing the inflammatory response mediated by pericytes after cerebral ischemia.
    Yang E; Cai Y; Yao X; Liu J; Wang Q; Jin W; Wu Q; Fan W; Qiu L; Kang C; Wu J
    Aging (Albany NY); 2019 Nov; 11(22):10167-10182. PubMed ID: 31740626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia.
    Deguchi K; Liu N; Liu W; Omote Y; Kono S; Yunoki T; Deguchi S; Yamashita T; Ikeda Y; Abe K
    J Neurosci Res; 2014 Nov; 92(11):1509-19. PubMed ID: 24938625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate protects against kainate-induced epileptic brain damage in rats.
    Kim TY; Yi JS; Chung SJ; Kim DK; Byun HR; Lee JY; Koh JY
    Exp Neurol; 2007 Nov; 208(1):159-67. PubMed ID: 17905231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling.
    Takeshita T; Nakagawa S; Tatsumi R; So G; Hayashi K; Tanaka K; Deli MA; Nagata I; Niwa M
    Mol Cell Neurosci; 2014 May; 60():1-9. PubMed ID: 24472843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal toxicity of commercial tissue plasminogen activator is mediated by the induction of nitric oxide in the mouse retinal primary cells.
    Oh HS; Kwon OW; Chung I; Lee SC; Koh HJ; Lee SH; Lee JH
    Curr Eye Res; 2005 Apr; 30(4):291-7. PubMed ID: 16020259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-Type Plasminogen Activator-A296-299 Prevents Impairment of Cerebral Autoregulation After Stroke Through Lipoprotein-Related Receptor-Dependent Increase in cAMP and p38.
    Armstead WM; Riley J; Yarovoi S; Higazi AA; Cines DB
    Stroke; 2016 Aug; 47(8):2096-102. PubMed ID: 27354223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection by pyruvate of rat retinal cells against zinc toxicity in vitro, and pressure-induced ischemia in vivo.
    Yoo MH; Lee JY; Lee SE; Koh JY; Yoon YH
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1523-30. PubMed ID: 15111611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc-triggered induction of tissue plasminogen activator and plasminogen in endothelial cells and pericytes.
    Cho MK; Sun ES; Kim YH
    Exp Neurobiol; 2013 Dec; 22(4):315-21. PubMed ID: 24465147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain endothelial hemostasis regulation by pericytes.
    Kim JA; Tran ND; Li Z; Yang F; Zhou W; Fisher MJ
    J Cereb Blood Flow Metab; 2006 Feb; 26(2):209-17. PubMed ID: 16015279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
    Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
    Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity.
    Liot G; Roussel BD; Lebeurrier N; Benchenane K; López-Atalaya JP; Vivien D; Ali C
    J Neurochem; 2006 Sep; 98(5):1458-64. PubMed ID: 16800849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator.
    Kim YH; Park JH; Hong SH; Koh JY
    Science; 1999 Apr; 284(5414):647-50. PubMed ID: 10213688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model.
    Aoki M; Morishita R; Hayashi S; Jo N; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Diabetologia; 2001 Aug; 44(8):1034-42. PubMed ID: 11484082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia.
    Hase Y; Okamoto Y; Fujita Y; Kitamura A; Nakabayashi H; Ito H; Maki T; Washida K; Takahashi R; Ihara M
    Exp Neurol; 2012 Jan; 233(1):523-33. PubMed ID: 22173318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fibrinolytic system attenuates vascular tone: effects of tissue plasminogen activator (tPA) and aminocaproic acid on renal microcirculation.
    Heyman SN; Hanna Z; Nassar T; Shina A; Akkawi S; Goldfarb M; Rosen S; Higazi AA
    Br J Pharmacol; 2004 Mar; 141(6):971-8. PubMed ID: 14993107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.